ALLIANCE PHARMA PLC

Declaration of Voting Results & Voting Rights Announcements • May 19, 2021

National Storage Mechanism | Additional information

RNS Number : 1791Z

Alliance Pharma PLC

19 May 2021

For immediate release	19 May 2021

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Result of AGM

Alliance Pharma plc (AIM: APH), the international healthcare group, announces that, at its Annual General Meeting held earlier today, all the resolutions, as set out in the Notice of Meeting, were duly passed on a poll.

The votes were as follows:

RESOLUTION		VOTES FOR	%	VOTES AGAINST	%	VOTES TOTAL	% OF ISC VOTED	VOTES WITHHELD
1	Report and Accounts	370,082,283	99.99	2,000	0.01	370,084,283	69.20	365,173
2	Final dividend	370,448,446	100.00	0	0.00	370,448,446	69.27	1,010
3	Re-elect D. Cook	364,919,306	98.52	5,491,119	1.48	370,410,425	69.26	39,031
4	Re-elect P. Butterfield	369,183,937	99.67	1,229,509	0.33	370,413,446	69.26	36,010
5	Re-elect A. Franklin	368,811,050	99.57	1,602,396	0.43	370,413,446	69.26	36,010
6	Re-elect J. LeCouilliard	369,062,346	99.64	1,351,100	0.36	370,413,446	69.26	36,010
7	Re-elect R. Jones	369,069,846	99.64	1,340,579	0.36	370,410,425	69.26	39,031
8	Re-appoint Auditor	370,335,621	99.98	82,835	0.02	370,418,456	69.26	31,000
9	Remuneration of Auditor	370,375,357	99.99	43,099	0.01	370,418,456	69.26	31,00
10	Allot shares	322,454,915	87.05	47,976,358	12.95	370,431,273	69.26	18,183
11	Disapply Pre-emption rights	310,764,742	83.89	59,666,531	16.11	370,431,273	69.26	18,183

The number of the Group's shares in issue as at the date of the meeting was 534,827,034 ordinary shares of 1p each.

Please note that each share carries one vote and that a 'vote withheld' is not a vote in law and has not been counted in the calculation of the proportion of the votes for and against the resolution. Any proxy appointments which gave discretion to the Chairman have been included in the 'votes for' total.

Chris Chrysanthou

Head of Legal & Company Secretary

19 May 2021

For further information:

Alliance Pharma plc	+ 44 (0)1249 466966
Peter Butterfield, Chief Executive Officer
Andrew Franklin, Chief Financial Officer
www.alliancepharma.co.uk
Buchanan	+ 44 (0)20 7466 5000
Mark Court / Sophie Wills / Hannah Ratcliff
Numis Securities Limited	+ 44 (0)20 7260 1000
Nominated Adviser: Freddie Barnfield / Oliver Steele
Corporate Broking: James Black

Investec Bank plc	+ 44 (0) 20 7597 5970
Corporate Finance: Daniel Adams
Corporate Broking: Patrick Robb

About Alliance

Alliance Pharma plc (AIM: APH) is an international healthcare group, headquartered in the UK with subsidiaries in Europe, the Far East and the US and wide international reach through an extensive network of distributors, generating sales in more than 100 countries.

We hold the marketing rights to around 80 Consumer Healthcare brands and Prescription Medicines, which are managed on a portfolio basis according to their growth potential. Promotional investment is focused primarily on our Consumer healthcare brands, many of which have significant international or multi-territory reach. Our Prescription Medicines are generally sold in a more limited number of local markets, and most require little or no promotional investment.

Our strategy allows us to deliver good organic growth and to enhance our growth rate through carefully selected acquisitions.

For more information on Alliance, please visit our website: www.alliancepharmaceuticals.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGDKCBPBBKDQPD